Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-84,964
Closed -$240K 1577
2022
Q3
$240K Buy
84,964
+68,529
+417% +$194K ﹤0.01% 1586
2022
Q2
$41K Buy
+16,435
New +$46.9K ﹤0.01% 1810
2022
Q1
Sell
-16,880
Closed -$47K 2136
2021
Q4
$47K Sell
16,880
-56,920
-77% -$163K ﹤0.01% 2039
2021
Q3
$204K Sell
73,800
-208,297
-74% -$659K ﹤0.01% 1771
2021
Q2
$970K Buy
+282,097
New +$918K 0.01% 1028
2019
Q4
Sell
-22,714
Closed -$105K 1484
2019
Q3
$105K Sell
22,714
-5,703
-20% -$27.3K ﹤0.01% 1227
2019
Q2
$133K Sell
28,417
-6,497
-19% -$29.1K 0.01% 992
2019
Q1
$150K Buy
+34,914
New +$160K 0.01% 589

Other funds holding ABEV

Michael Gelband's ABEV Position: Q4 2022 in Review

Michael Gelband sold out of Ambev (ABEV) in Q4 2022, closing a stake of 84,964 shares — an estimated $240K sold.

Michael Gelband first reported a position in ABEV in Q1 2019 and held it in 8 quarters. The position peaked at $970K in Q2 2021. 314 funds tracked by Wall St. Rank hold ABEV as of Q4 2022.

  • Michael Gelband reported no remaining Ambev position as of Q4 2022 after selling out during the quarter.
  • Michael Gelband sold 84,964 Ambev shares in Q4 2022, an estimated $240K.
  • Michael Gelband first reported a position in Ambev in Q1 2019 and held it in 8 quarters.
  • Michael Gelband's Ambev position peaked at $970K in Q2 2021.
  • 314 funds tracked by Wall St. Rank held Ambev as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.